Pro-Dex, Inc. (PDEX) |
| 51.48 0.61 (1.2%) 04-10 16:00 |
| Open: | 50.35 |
| High: | 51.48 |
| Low: | 49.72 |
| Volume: | 17,002 |
| Market Cap: | 168(M) |
| PE Ratio: | 15.1 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 61.80 |
| Resistance 1: | 52.91 |
| Pivot price: | 49.35 |
| Support 1: | 47.18 |
| Support 2: | 43.64 |
| 52w High: | 70.26 |
| 52w Low: | 23.47 |
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Financials
| EPS | 3.410 |
| Book Value | 12.970 |
| PEG Ratio | 0.00 |
| Gross Profit | 6.355 |
| Profit Margin (%) | 15.73 |
| Operating Margin (%) | 17.46 |
| Return on Assets (ttm) | 11.6 |
| Return on Equity (ttm) | 30.9 |
Company news
Sat, 04 Apr 2026
PDEX PE Ratio & Valuation, Is PDEX Overvalued - Intellectia AI
Sun, 29 Mar 2026
PDEX Should I Buy - Intellectia AI
Sun, 25 Jan 2026
With 37% ownership, Pro-Dex, Inc. (NASDAQ:PDEX) has piqued the interest of hedge funds investors - Yahoo Finance
Sat, 17 Jan 2026
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount (NASDAQ:PDEX) - Seeking Alpha
Sat, 10 Jan 2026
We Think Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt With Ease - simplywall.st
Thu, 08 Jan 2026
Pro-Dex Valuation Is Attractive Despite Customer Risk (NASDAQ:PDEX) - Seeking Alpha
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
